How does the patient-management option of continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) affect the E/M risk level and overall level of medical decision making (MDM)? Because the provider must write a prescription for the device, would it fall under moderate risk, ie, similar to prescription drugs? ...
Subscribe or sign in to view the full article.
Article Overview
This short coding Q&A explains how the patient-management use of CPAP and BiPAP can factor into evaluation and management documentation, especially when assessing risk and overall medical decision making. It is aimed at coders, auditors, and clinicians who need a general understanding of how device management may be considered in relation to E/M service selection. The discussion focuses on broad judgment considerations, clinician involvement, and how the relevance of the therapy depends on who is managing it and the patient’s circumstances.
Why This Topic Matters
Understanding how CPAP and BiPAP management may influence E/M risk and MDM helps support more accurate documentation review and code selection.
What You Will Learn
- How CPAP and BiPAP management may be considered in E/M risk assessment
- How clinician involvement affects whether the therapy is relevant to MDM
- How ongoing device management is viewed in broad relation to patient risk
- How patient circumstances can influence the overall level of medical decision making
Who Should Read This
- Medical coders
- Coding auditors
- Clinicians
- Clinical documentation specialists
- Revenue cycle professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com